3526 - 3550 of 9034 Results
Title
Year
-
OPENTitle: Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease: a prospective cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 25Issue #: 4Start Page: 357End Page: 367Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(26)00029-3Best OA location URL: https://www.thelancet.com/pdfs/journals/laneur/PIIS1474-4422(26)00029-3.pdfCitation Count: 4
-
OPENTitle: Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotypeJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 30Issue #: 4Start Page: 1465End Page: 1483Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ymthe.2022.01.021Best OA location URL: http://www.cell.com/article/S1525001622000211/pdfCitation Count: 25
- Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)2018OPENTitle: Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)Journal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 77Issue #: 9Start Page: 793End Page: 802Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nly056Best OA location URL: https://academic.oup.com/jnen/article-pdf/77/9/793/25507335/nly056.pdfCitation Count: 37
-
OPENTitle: Small Molecule Improvement of Trafficking Defects in Models of NeurodegenerationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 21Start Page: 3972End Page: 3984Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.1c00524Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9754116Citation Count: 1
- Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variants2024RESTRICTEDTitle: Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variantsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 126Issue #:Start Page: 107041End Page: 107041Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107041Citation Count: 0
- Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial2025OPENTitle: Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized TrialJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 12Start Page: 2688End Page: 2699Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70028Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70028Citation Count: 4
- Validation of a performance‐based assessment of cognitive functional ability in Parkinson's disease2018OPENTitle: Validation of a performance‐based assessment of cognitive functional ability in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1760End Page: 1768Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27487Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6261681Citation Count: 21
- LRRK2 variation and Parkinson's disease in African Americans2010RESTRICTEDTitle: LRRK2 variation and Parkinson's disease in African AmericansJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1973End Page: 1976Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23163Citation Count: 14
-
OPENTitle: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 161End Page: 161Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0456-2Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0456-2Citation Count: 100
-
OPENTitle: Accelerating Medicines Partnership® Parkinson's Disease Proteomics: A Comprehensive Resource for Advancing Parkinson's Disease ResearchJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 4Start Page: 972End Page: 980Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.70183Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70183Citation Count: 0
- Early Detection of Parkinson's Disease Using an Ensemble Framework QuadFusionNet with Deep Learning and Explainable AI2025RESTRICTEDTitle: Early Detection of Parkinson's Disease Using an Ensemble Framework QuadFusionNet with Deep Learning and Explainable AIJournal Name: 2025 International Conference on Modeling, Simulation & Intelligent Computing (MoSICom)Publisher: IEEEVol:Issue #:Start Page: 316End Page: 321Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/mosicom67153.2025.11398248Citation Count: 0
-
OPENTitle: Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior DisorderJournal Name: Annals of NeurologyPublisher: WileyVol: 98Issue #: 3Start Page: 482End Page: 491Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.27263Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12392052Citation Count: 3
-
OPENTitle: Resistant starch improves Parkinson’s disease symptoms through restructuring of the gut microbiome and modulating inflammationJournal Name: Brain, Behavior, and ImmunityPublisher: Elsevier BVVol: 132Issue #:Start Page: 106217End Page: 106217Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbi.2025.106217Best OA location URL: https://doi.org/10.1016/j.bbi.2025.106217Citation Count: 2
-
OPENTitle: S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson’s Disease ModelsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 21Issue #: 8Start Page: 2171End Page: 2182Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2017.10.068Best OA location URL: http://www.cell.com/article/S2211124717315310/pdfCitation Count: 128
-
OPENTitle: Genetic analysis and natural history of Parkinson’s disease due to the LRRK2 G2019S variantJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 6Start Page: 1996End Page: 2008Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awae073Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae073/57762235/awae073.pdfCitation Count: 49
-
OPENTitle: A person-centered approach to characterizing longitudinal ambulatory impairment in Parkinson's diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 11509End Page: 11509Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-62179-9Best OA location URL: https://www.nature.com/articles/s41598-024-62179-9.pdfCitation Count: 1
-
OPENTitle: Dorsal Raphe Dopamine Neurons Modulate Arousal and Promote Wakefulness by Salient StimuliJournal Name: NeuronPublisher: Elsevier BVVol: 94Issue #: 6Start Page: 1205End Page: 1219.e8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuron.2017.05.020Best OA location URL: http://www.cell.com/article/S0896627317304580/pdfCitation Count: 283
-
OPENTitle: L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehiclesJournal Name: Nanomedicine: Nanotechnology, Biology and MedicinePublisher: Elsevier BVVol: 15Issue #: 1Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nano.2018.08.011Best OA location URL: http://hdl.handle.net/10044/1/63483Citation Count: 100
-
OPENTitle: Subspace corrected relevance learning with application in neuroimagingJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 149Issue #:Start Page: 102786End Page: 102786Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.artmed.2024.102786Best OA location URL: https://doi.org/10.1016/j.artmed.2024.102786Citation Count: 8
-
OPENTitle: Cadherin‐8 expression, synaptic localization, and molecular control of neuronal form in prefrontal corticostriatal circuitsJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 523Issue #: 1Start Page: 75End Page: 92Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.23666Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4232472Citation Count: 59
-
OPENTitle: Dying-back of ascending noradrenergic projections in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 9Start Page: 2562End Page: 2564Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab286Best OA location URL: https://academic.oup.com/brain/article-pdf/144/9/2562/40880422/awab286.pdfCitation Count: 7
- Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patients2017RESTRICTEDTitle: Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1423End Page: 1431Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27136Citation Count: 175
- Using Voluntary Cough To Detect Penetration and Aspiration During Oropharyngeal Swallowing in Patients With Parkinson Disease2010RESTRICTEDTitle: Using Voluntary Cough To Detect Penetration and Aspiration During Oropharyngeal Swallowing in Patients With Parkinson DiseaseJournal Name: ChestPublisher: Elsevier BVVol: 138Issue #: 6Start Page: 1426End Page: 1431Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1378/chest.10-0342Citation Count: 94
-
OPENTitle: DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s diseaseJournal Name: GeroSciencePublisher: Springer Science and Business Media LLCVol: 46Issue #: 5Start Page: 4349End Page: 4371Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11357-024-01116-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11357-024-01116-0.pdfCitation Count: 24
-
OPENTitle: General anaesthesia decreases the uniqueness of brain functional connectivity across individuals and speciesJournal Name: Nature Human BehaviourPublisher: Springer Science and Business Media LLCVol: 9Issue #: 5Start Page: 987End Page: 1004Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41562-025-02121-9Best OA location URL: https://www.nature.com/articles/s41562-025-02121-9.pdfCitation Count: 15